Lineweaver Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.08M Buy
2,569
+205
+9% +$209K 0.36% 61
2026
Q1
$2.17M Sell
2,364
-54
-2% -$54.7K 0.29% 73
2025
Q4
$2.6M Buy
2,418
+74
+3% +$70.8K 0.35% 56
2025
Q3
$1.79M Sell
2,344
-408
-15% -$304K 0.26% 75
2025
Q2
$2.15M Buy
2,752
+433
+19% +$336K 0.34% 58
2025
Q1
$1.92M Sell
2,319
-14
-0.6% -$11.6K 0.33% 60
2024
Q4
$1.8M Buy
2,333
+118
+5% +$97.7K 0.33% 60
2024
Q3
$1.96M Buy
2,215
+151
+7% +$136K 0.37% 50
2024
Q2
$1.87M Sell
2,064
-47
-2% -$37.6K 0.39% 48
2024
Q1
$1.65M Buy
2,111
+61
+3% +$43.4K 0.39% 53
2023
Q4
$1.2M Buy
2,050
+1,176
+135% +$686K 0.31% 65
2023
Q3
$470K Buy
+874
New +$450K 0.14% 96

Other funds holding LLY

Lineweaver Wealth Advisors's LLY Position: Q2 2026 in Review

Lineweaver Wealth Advisors increased its Eli Lilly (LLY) stake by 8.7% in Q2 2026, buying an estimated $209K and bringing the position to 2,569 shares worth $3.08M. The position accounts for 0.36% of the portfolio, ranked #61.

Lineweaver Wealth Advisors first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lineweaver Wealth Advisors held 2,569 shares of Eli Lilly worth $3.08M as of Q2 2026.
  • Lineweaver Wealth Advisors bought 205 Eli Lilly shares in Q2 2026, an estimated $209K.
  • Eli Lilly made up 0.36% of Lineweaver Wealth Advisors's portfolio in Q2 2026, its #61 holding.
  • Lineweaver Wealth Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lineweaver Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.